NASDAQ · LIEN
Chicago Atlantic BDC, Inc.
$9.11-$0.05 (-0.49%)
Chicago Atlantic BDC, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.21% below the high.
Loading market information…
NASDAQ · VLNS · USD
Stock price, earnings
Quote as of Jan 13, 2023, 08:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
The Valens Company Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow The Valens Company Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The Valens Company Inc. is a Canadian-headquartered enterprise with international reach, focused on the development, manufacturing, and sale of cannabinoid-based products. Its product portfolio encompasses dried cannabis and hemp biomass, alongside a wide array of consumer goods such as tinctures, two-piece caps, soft gels, oral sprays, vape pens, beverages, diverse concentrates, topicals, edibles, and natural health products. Additionally, Valens provides a comprehensive suite of services, including various extraction techniques (CO2, ethanol, hydrocarbon, solvent-less, and terpene), analytical testing, formulation, product development, and custom manufacturing. The company, formerly known as Valens Groworks Corp., officially changed its name to The Valens Company Inc. in June 2020.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$9.11-$0.05 (-0.49%)
Chicago Atlantic BDC, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.21% below the high.
$1.30+$0.03 (+2.36%)
Zynerba Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.14% below the high.
$1.07-$0.01 (-0.93%)
Surface Oncology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.17% below the high.
$1.29-$0.07 (-5.15%)
Akoya Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.28% below the high.
$2.38+$0.01 (+0.42%)
Heat Biologics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 4.03% below the high.
$6.75$0.00 (0.0%)
NeueHealth, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.84% below the high.
$18.20+$16.47 (+952.02%)
Reneo Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.05% below the high.
$1.48+$0.01 (+0.68%)
Achilles Therapeutics plc’s quoted price sits in the upper half of its reported 52-week range, 1.99% below the high.
